International Clinical Trial: A prospective, multicenter, double-blind, double-dummy, randomized controlled clinical study to evaluate the efficacy and safety of clonidine in the treatment of primary restless legs syndrome (RLS)

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114925) titled 'A prospective, multicenter, double-blind, double-dummy, randomized controlled clinical study to evaluate the efficacy and safety of clonidine in the treatment of primary restless legs syndrome (RLS)' on Dec. 19, 2025.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Shanghai General Hospital

Condition: Restless legs syndrome

Intervention: Pramipexole Group:Pramipexole + Grisugabalin placebo

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2025-12-31

Target Sample Size: Pramipexole Group:58;Grisugabalin Group:58;

Countries of Recruitment: China

To kno...